Genmab Data From Pivotal Phase 3 EPCORE FL-1 Study Of Epcoritamab In Combination With Rituximab And Lenalidomide Demonstrates Consistent, Sustained Efficacy Benefits Throughout Clinically Relevant Subgroups

뉴스 본문을 불러오고 있어요.

Genmab Data From Pivotal Phase 3 EPCORE FL-1 Study Of Epcoritamab In Combination With Rituximab And Lenalidomide Demonstrates Consistent, Sustained Efficacy Benefits Throughout Clinically Relevant Subgroups | 웨이프 WAPE

Genmab Data From Pivotal Phase 3 EPCORE FL-1 Study Of Epcoritamab In Combination With Rituximab And Lenalidomide Demonstrates Consistent, Sustained Efficacy Benefits Throughout Clinically Relevant Subgroups

기사 요약

관련 종목

댓글 —